Growth Metrics

Eton Pharmaceuticals (ETON) Cash from Investing Activities (2020 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Cash from Investing Activities for 6 consecutive years, with -$49000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 99.87% to -$49000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$333000.0 through Dec 2025, up 99.17% year-over-year, with the annual reading at -$333000.0 for FY2025, 99.17% up from the prior year.
  • Cash from Investing Activities hit -$49000.0 in Q4 2025 for Eton Pharmaceuticals, up from -$284000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$2000.0 in Q3 2021 to a low of -$38.1 million in Q4 2024.
  • Historically, Cash from Investing Activities has averaged -$4.3 million across 5 years, with a median of -$761000.0 in 2022.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 99900.0% in 2022 and later soared 99.87% in 2025.
  • Year by year, Cash from Investing Activities stood at -$3.3 million in 2021, then skyrocketed by 99.63% to -$12000.0 in 2022, then tumbled by 6358.33% to -$775000.0 in 2023, then plummeted by 4820.26% to -$38.1 million in 2024, then surged by 99.87% to -$49000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for ETON at -$49000.0 in Q4 2025, -$284000.0 in Q3 2025, and -$38.1 million in Q4 2024.